ArticleACS omega2020
A Pan-Specific GRU-Based Recurrent Neural Network for Predicting HLA-I-Binding Peptides.
Article in ACS omega, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 13 citations in OpenAlex.
- Deciphering the selective binding mechanisms of anaplastic lymphoma kinase-derived neuroblastoma tumor neoepitopes to human leukocyte antigen.Journal of molecular modeling · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human leukocyte antigens (HLAs) play a critical role in human-acquired immune responses by the recognition of non-self-peptides derived from exogenous bacteria, fungi, virus, and so forth. The accurate prediction of HLA-binding peptides is thus extremely useful for the mechanistic research of cell-mediated immunity and related epitope-based vaccine design. In this work, a simple pan-specific gated recurrent unit (GRU)-based recurrent neural network model was successfully proposed for predicting HLA-I-binding peptides. In comparison with the available six allele-specific, four pan-specific, and two ensemble-based prediction models, the GRU model achieves the highest area under the receiver operating characteristic curve (AUC) scores for 21 of 64 entries of the test benchmark datasets. Besides, the GRU model also achieves satisfactory performance on other 24 entries, of which the AUC scores differ by less than 0.1 from the highest scores. Overall, taking the advantages of the GRU network and auto-embedding techniques into account, the established pan-specific GRU model is more simple and direct and shows satisfactory prediction performance for HLA-I-binding peptides with varying lengths.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.